Treatment of Oral Warts in HIV+ Patients

• Status: Completed
• Trial end date: 2009-10-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a study to test lozenges of interferon-alpha that are dissolved in the mouth as a treatment of oral warts in HIV-positive adults.

The hypothesis of this study is that interferon-alpha will be safe and that a higher percentage of subjects given interferon-alpha will experience a complete or nearly complete remission of their oral warts compared to subjects given placebo.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Amarillo Biosciences, Inc.
• Treatments: Interferon-alpha; Interferons

Criteria

Inclusion Criteria:

• Must have tested positive for HIV.

• Must have two or more warts inside the mouth.

• Must be receiving a standard course of anti-retroviral therapy (HAART).

Exclusion Criteria:

• Must not be receiving oral or injected steroids.

• Must not be taking other drugs for treatment of oral warts.

• Must not have other active HIV-related opportunistic infections.